Filter
660
Filtered Results: 660
Text search:
vaccine
carriers
Featured
Recommendations
80
New Publications
205
Language
Document type
No document type
363
Guidelines
113
Studies & Reports
85
Manuals
44
Strategic & Response Plan
22
Fact sheets
16
Situation Updates
9
Training Material
4
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
India
38
Global
23
Nigeria
19
Liberia
18
South Africa
17
Kenya
16
Uganda
15
Sierra Leone
14
Nepal
13
Tanzania
13
Congo, Democratic Republic of
12
Philippines
11
Africa
10
Ghana
9
Rwanda
9
Latin America and the Carribbean
9
Ethiopia
9
Ukraine
8
Guinea
8
Zambia
8
Cameroon
6
Senegal
6
Western and Central Europe
6
Bangladesh
6
Syria
5
Malawi
5
West and Central Africa
5
Namibia
5
Zimbabwe
4
Haiti
4
Germany
4
East and Southern Africa
4
Central African Republic
4
Botswana
4
South Sudan
4
Benin
3
Burkina Faso
3
Mozambique
3
Cambodia
3
South–East Asia Region
3
Western Pacific Region
3
Eastern Europe
3
Brazil
3
Sudan
3
Indonesia
3
Myanmar / Burma
3
Lesotho
2
Turkey
2
Laos
2
Venezuela
2
Jordan
2
Côte d’Ivoire / Ivory Coast
2
Vietnam
2
Russia
2
Mali
2
Eswatini/ Swaziland
2
Pakistan
2
North Macedonia
1
Tajikistan
1
Colombia
1
Timor Leste/ East Timor
1
Chile
1
Iran
1
Niger
1
Afghanistan
1
Burundi
1
Peru
1
Morocco
1
Asia
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Paraguay
1
North America
1
Gabon
1
Denmark
1
France
1
Maldives
1
Tunisia
1
United Kingdom
1
Portugal
1
Spain
1
Southern Africa
1
Bolivia
1
Argentina
1
Lebanon
1
Papua New Guinea
1
Egypt
1
Yemen
1
Georgia
1
Angola
1
Chad
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
261
Clinical Guidelines
80
Public Health
43
Key Resources
32
Women & Child Health
28
Pharmacy & Technologies
13
Capacity Building
11
Toolboxes
COVID-19
80
Rapid Response
41
AMR
31
Ebola & Marburg
29
NTDs
29
HIV
26
Pharmacy
22
Conflict
18
TB
15
Refugee
14
Polio
14
Cholera
13
Global Health Education
11
Caregiver
10
Planetary Health
9
Natural Hazards
7
Zika
7
Mental Health
6
Specific Hazards
6
Health Financing Toolbox
4
Disability
2
NCDs
2
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident...
The WHO Guide on Oral Cholera Vaccines in Mass Immunization Campaigns provides guidance on the planning and implementation of oral cholera vaccine (OCV) campaigns. It covers key aspects such as when and where to use OCVs, vaccine specifications, and recommendations for use in endemic areas, outbreak...
The technical note by the Global Task Force on Cholera Control (GTFCC) discusses the use of Oral Cholera Vaccines (OCVs) for international workers and travelers in cholera-affected areas. It reviews the effectiveness of WHO-prequalified vaccines (Dukoral®, Shanchol™, and Euvichol®), emphasizing ...
Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at the start of the pandemic, which resulted in delays in obtaining COVID-19 doses, stimulated new resolve to address future...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)
recommended
4 August 2021. Currently, Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran) is the only COVID-19 vaccine that should be stored and transported at -60ºC to -86ºC ultra-low temperature (ULT) conditions. Prior to use the vaccine can be transferred to -20ºC freezer or +2-8ºC refrigerator at...
The purpose of this field guide is to provide comprehensive information on planning and implementing high-quality3 SIAs for injectable vaccines and highlight the opportunities to strengthen RI and surveillance. The guide uses measles–rubella SIAs as the main example throughout, but the informatio...
The overall goal of this strategy is to ensure accurate understanding of the
benefits of covid-19 vaccination and alleviate apprehension about the vaccine, to ensure its acceptance and encourage uptake across various audiences.
Objectives
x Create demand, promote acceptability and accessibility o...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
of highly contagious viruses (of the Ebola or Marburg type) in the context of an epidemic outbreak in West Africa
Robust clinical research capacity in low- and middle-income countries is key to stemming the spread of epidemics, according to a new report from the International Vaccines Task Force (IVTF). The report lays out how to develop the political support, financing and coordination required to build this c...
Working Document Nov. 2020
The COVAX Supply and Logistics workstream lead by UNICEF, Gavi and WHO have released a working copy of the COVID-19 Vaccination, Country Readiness & Delivery: Supply and Logistics Guidance. Countries might find this Guide useful when developing and strengthening their sup...
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following the successful roll-out of this vaccine, epidemics due to Neisseria meningitidis serogroup A (NmA) are...
